Interferon production by human mononuclear leukocytes: differences between respiratory syncytial virus and influenza viruses
- PMID: 6163726
- PMCID: PMC350621
- DOI: 10.1128/iai.32.1.300-303.1981
Interferon production by human mononuclear leukocytes: differences between respiratory syncytial virus and influenza viruses
Abstract
The ability of respiratory syncytial virus (RSV) to induce interferon production by human mononuclear leukocytes was compared with that of influenza viruses. Cell culture fluids were assayed for interferon activity 1, 3 and 7 days after exposure to RSV or to one of two subtypes of influenza A virus (H0N1 and H3N2). RSV induced interferon production inconsistently and in low titers. Varying the multiplicity of infection did not improve the ability of RSV to induce interferon production. In contrast, influenza viruses were effective inducers of interferon production. Seropositivity to the influenza virus strains was not associated with increased interferon titers. Interferon produced after exposure to RSV or to the influenza viruses was resistant to low pH treatment. The data suggest that interferon production may not be a major component of human immunological defense against RSV infection.
Similar articles
-
The limited role of the human interferon system response to respiratory syncytial virus challenge: analysis and comparison to influenza virus challenge.Microb Pathog. 1992 Jun;12(6):409-14. doi: 10.1016/0882-4010(92)90003-7. Microb Pathog. 1992. PMID: 1522795
-
Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections.J Pediatr. 1978 Jul;93(1):28-32. doi: 10.1016/s0022-3476(78)80594-0. J Pediatr. 1978. PMID: 206677
-
Effect of aging on cytokine production in response to respiratory syncytial virus infection.J Infect Dis. 2002 Mar 1;185(5):682-5. doi: 10.1086/339008. Epub 2002 Feb 14. J Infect Dis. 2002. PMID: 11865426
-
Respiratory syncytial virus infection of primary human mast cells induces the selective production of type I interferons, CXCL10, and CCL4.J Allergy Clin Immunol. 2015 Nov;136(5):1346-54.e1. doi: 10.1016/j.jaci.2015.01.042. Epub 2015 Mar 24. J Allergy Clin Immunol. 2015. PMID: 25819983
-
Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease.Virology. 2015 Feb;476:217-225. doi: 10.1016/j.virol.2014.12.004. Epub 2014 Dec 30. Virology. 2015. PMID: 25553517 Free PMC article.
Cited by
-
Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus.Immunology. 1994 May;82(1):126-33. Immunology. 1994. PMID: 7519169 Free PMC article.
-
Reduced activation and proliferation of human lymphocytes exposed to respiratory syncytial virus compared to cells exposed to influenza virus.J Med Virol. 2018 Jan;90(1):26-33. doi: 10.1002/jmv.24917. Epub 2017 Sep 26. J Med Virol. 2018. PMID: 28856681 Free PMC article.
-
Induction of type I interferons and interferon-inducible Mx genes during respiratory syncytial virus infection and reinfection in cotton rats.J Gen Virol. 2008 Jan;89(Pt 1):261-270. doi: 10.1099/vir.0.83294-0. J Gen Virol. 2008. PMID: 18089750 Free PMC article.
-
A Celebration of the Life and Work of Caroline Breese Hall, MD.J Pediatric Infect Dis Soc. 2016 Mar;5(1):e1-4. doi: 10.1093/jpids/piu118. Epub 2014 Dec 8. J Pediatric Infect Dis Soc. 2016. PMID: 26908498 Free PMC article. No abstract available.
-
Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus.Clin Exp Immunol. 2007 Nov;150(2):263-73. doi: 10.1111/j.1365-2249.2007.03497.x. Epub 2007 Sep 24. Clin Exp Immunol. 2007. PMID: 17892510 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources